NM_001048174.2(MUTYH):c.32G>A (p.Gly11Asp) AND not specified

Germline classification:: Conflicting interpretations of pathogenicity (4 submissions)
Last evaluated:: Jul 31, 2024
Review status:: criteria provided, conflicting classifications

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000121606.35

Allele description [Variation Report for NM_001048174.2(MUTYH):c.32G>A (p.Gly11Asp)]

NM_001048174.2(MUTYH):c.32G>A (p.Gly11Asp)

Gene:

MUTYH:mutY DNA glycosylase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

1p34.1

Genomic location:

Preferred name:

NM_001048174.2(MUTYH):c.32G>A (p.Gly11Asp)

Other names:

p.G25D:GGT>GAT

HGVS:

NC_000001.11:g.45334474C>T
NG_008189.1:g.10997G>A
NM_001048171.2:c.32G>A
NM_001048172.2:c.32G>A
NM_001048173.2:c.32G>A
NM_001048174.2:c.32G>AMANE SELECT
NM_001128425.2:c.74G>A
NM_001293190.2:c.74G>A
NM_001293191.2:c.32G>A
NM_001293192.2:c.-181G>A
NM_001293195.2:c.32G>A
NM_001293196.2:c.-181G>A
NM_001350650.2:c.-240G>A
NM_001350651.2:c.-176G>A
NM_012222.3:c.74G>A
NP_001041636.1:p.Gly25Asp
NP_001041636.2:p.Gly11Asp
NP_001041637.1:p.Gly11Asp
NP_001041638.1:p.Gly11Asp
NP_001041639.1:p.Gly11Asp
NP_001121897.1:p.Gly25Asp
NP_001121897.1:p.Gly25Asp
NP_001280119.1:p.Gly25Asp
NP_001280120.1:p.Gly11Asp
NP_001280124.1:p.Gly11Asp
NP_036354.1:p.Gly25Asp
NP_036354.1:p.Gly25Asp
LRG_220t1:c.74G>A
LRG_220:g.10997G>A
LRG_220p1:p.Gly25Asp
NC_000001.10:g.45800146C>T
NM_001048171.1:c.74G>A
NM_001128425.1:c.74G>A
NM_012222.2:c.74G>A
NR_146882.2:n.260G>A
NR_146883.2:n.183G>A
p.G25D

Protein change:

G11D

Links:

dbSNP: rs75321043

NCBI 1000 Genomes Browser:

rs75321043

Molecular consequence:

NM_001293192.2:c.-181G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001293196.2:c.-181G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001350650.2:c.-240G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001350651.2:c.-176G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001048171.2:c.32G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001048172.2:c.32G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001048173.2:c.32G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001048174.2:c.32G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001128425.2:c.74G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001293190.2:c.74G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001293191.2:c.32G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001293195.2:c.32G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_012222.3:c.74G>A - missense variant - [Sequence Ontology: SO:0001583]
NR_146882.2:n.260G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_146883.2:n.183G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000085804	ITMI	no classification provided	not provided	germline	reference population	PubMed (1) [See all records that cite this PMID]
SCV000539815	Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	criteria provided, single submitter (LMM Criteria)	Benign (Mar 29, 2016)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV000806367	PreventionGenetics, part of Exact Sciences	criteria provided, single submitter (ACMG Guidelines, 2015)	Benign (Aug 2, 2017)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV002552531	Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Jul 31, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing
African	germline	unknown	not provided	not provided	not provided	43	not provided	reference population
African_European	germline	unknown	not provided	not provided	not provided	46	not provided	reference population
Central_Asian	germline	unknown	not provided	not provided	not provided	50	not provided	reference population
East_Asian	germline	unknown	not provided	not provided	not provided	62	not provided	reference population
European	germline	unknown	not provided	not provided	not provided	331	not provided	reference population
Hispanic	germline	unknown	not provided	not provided	not provided	118	not provided	reference population
Whole_cohort	germline	unknown	not provided	not provided	not provided	681	not provided	reference population

Citations

PubMed

Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.

Bodian DL, McCutcheon JN, Kothiyal P, Huddleston KC, Iyer RK, Vockley JG, Niederhuber JE.

PLoS One. 2014;9(4):e94554. doi: 10.1371/journal.pone.0094554.

PubMed [citation]

PMID:: 24728327
PMCID:: PMC3984285

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]

PMID:: 24033266
PMCID:: PMC3995020

See all PubMed Citations (3)

Details of each submission

From ITMI, SCV000085804.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	African	not provided	not provided	not provided	reference population	PubMed (1)
2	African_European	not provided	not provided	not provided	reference population	PubMed (1)
3	Central_Asian	not provided	not provided	not provided	reference population	PubMed (1)
4	East_Asian	not provided	not provided	not provided	reference population	PubMed (1)
5	European	not provided	not provided	not provided	reference population	PubMed (1)
6	Hispanic	not provided	not provided	not provided	reference population	PubMed (1)
7	Whole_cohort	not provided	not provided	not provided	reference population	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	43	not provided	discovery		not provided	0	not provided	not provided
2	germline	unknown	46	not provided	discovery		not provided	0	not provided	not provided
3	germline	unknown	50	not provided	discovery		not provided	0	not provided	not provided
4	germline	unknown	62	not provided	discovery		not provided	0	not provided	not provided
5	germline	unknown	331	not provided	discovery		not provided	0	not provided	not provided
6	germline	unknown	118	not provided	discovery		not provided	0	not provided	not provided
7	germline	unknown	681	not provided	discovery		not provided	0.0007	not provided	not provided

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000539815.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC: 1.3% (114/8654) East Asian chromosomes; ClinVar: 4 labs classify as VUS

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From PreventionGenetics, part of Exact Sciences, SCV000806367.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, SCV002552531.5

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 20, 2024

ClinVar

Relating variation to medicine